Short Bowel Syndrome
126
12
17
74
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
34 trials with published results (27%)
Research Maturity
74 completed trials (59% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
8.7%
11 terminated out of 126 trials
87.1%
+0.6% vs benchmark
31%
39 trials in Phase 3/4
46%
34 of 74 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 74 completed trials
Clinical Trials (126)
Evaluation of the Efficacy and Safety of Recombinant Human Growth Hormone (rhGH) in the Treatment of Children With Short Bowel Syndrome
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
A Study of Teduglutide in Japanese People With Short Bowel Syndrome
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)
Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial
Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS
Palliative Care Needs of Children With Rare Diseases and Their Families
A 90 Day Observational Study as an Extension to the Phase 3,Open Labeled Exploratory Study of RELiZORB
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
Gastrointestinal Hormone Secretion, Intestinal Permeability and Short Bowel Syndrome
Registry for Participants With Short Bowel Syndrome
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
Effect of Parenteral Support on FibroScan in Short Bowel Syndrome
Assessing Metabolic and Sleep Consequences of Overnight Home Parenteral Nutrition
Specific Dietary Fibers May Enhance Colonic Adaptation in Short Bowel Syndrome Through Microbial and Metabolic Mechanisms That Drive Functional Compensation.
Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric Patients
Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)